Search

everythinglearnresearchcommunity

for

Search:↓

Frontal Fibrosing Alopecia is a poorly understood condition that is hard to treat and causes distressing hair loss.

Radiation therapy in breast cancer patients changes gene expression related to DNA damage, fibroblast growth, and hair follicle development, which could help improve treatment for radiation-induced fibrosis.

Breast cancer patients taking CDK4/6 inhibitors are more likely to experience fatigue, hair loss, and mouth sores.

Various potential triggers may be causing the rise in frontal fibrosing alopecia, and avoiding these could help stop the disease's increase.

Tofacitinib can help hair grow back in alopecia patients but hair loss might return if the dose is lowered.

Optimized liposomes can improve drug delivery and effectiveness.

Using a specific binding agent and low doses of FK506 can stimulate stem cells, speeding up skin healing by 25% and improving skin quality in rats and mice.

Researchers found three patterns of Frontal fibrosing alopecia, with Pattern III having the best prognosis after treatment.

Tofacitinib was effective for severe, treatment-resistant hair loss without side effects.

Switching between the medications tofacitinib and baricitinib can be effective for treating hair loss in alopecia areata.

Oral dutasteride can potentially treat frontal fibrosing alopecia in postmenopausal women, with some patients showing disease arrest and hair regrowth.

Finasteride, a medication, is being re-evaluated for its effects and uses.

Ruxolitinib may help treat hair loss and symptoms in patients with chronic graft-versus-host disease.

Isotretinoin with tacrolimus may be more effective short-term for treating frontal fibrosing alopecia than finasteride with tacrolimus.

Recognizing diverse presentations of folliculotropic mycosis fungoides is crucial to avoid diagnostic errors.

Frontal fibrosing alopecia can be managed with personalized combination therapies, but no cure exists yet.

P-3074 effectively blocks scalp DHT better than oral finasteride.

Folate may reduce methotrexate side effects in psoriasis patients, but its impact on effectiveness is unclear.

Promising cancer treatments were found, but the manufacturer closed.

Low-dose naltrexone helps improve symptoms and stabilize frontal fibrosing alopecia and lichen planopilaris.

The 595-nm pulsed dye laser effectively reduces symptoms of EFFC with minimal side effects.

Tofacitinib can temporarily improve hair growth in alopecia universalis, but its effectiveness may decrease over time.

FoxA is crucial for pharynx regeneration in planarian flatworms.

The treatment combining docetaxel, cisplatin, and 5-FU is feasible and effective for advanced head and neck cancer.

Temporary hair loss can occur after 5-fluorouracil treatment for keloids.